Prestige Brands Holdings, Incorporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Prestige Brands Holdings, Incorporation with three other
pharmaceutical manufacturers in North America:
sales of $361.59 million
China Yct International Group, Inc.
Peregrine Pharmaceuticals, Inc.
of which 100%
was Contract Manufacturing and Development o).
During the year ended March of 2017, sales at
Prestige Brands Holdings, Incorporation were $882.06 million.
increase of 9.4%
versus 2016, when the company's sales were $806.25 million.
This was the third consecutive year of growth at Prestige Brands Holdings, Incorporation.
Sales of North Ameriican Otc Healthcare saw an increase
9.6% in 2017, from
$657.87 million to $720.82 million.
Not all segments of Prestige Brands Holdings, Incorporation experienced an increase in sales in 2017:
sales of International Otc Healthcare fell 19.1% to $73.30 million.